Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 502 SEK 2.14% Market Closed
Market Cap: 15.8B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

270.9
Current
240.9
Median
12.9
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
270.9
=
Enterprise Value
15.4B SEK
/
EBITDA
56.8m SEK
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
82.1
2-Years Forward
EV/EBITDA
46.6
3-Years Forward
EV/EBITDA
29.6